HCW Biologics Inc. (HCWB) Free cash flow 2020–2025
HCW Biologics Inc. (HCWB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$13.4MFY2025 · since FY2020: -$10.6M → -$13.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.4M | +7.6% |
| FY2024 | -$14.5M | +49.5% |
| FY2023 | -$28.7M | -39.0% |
| FY2022 | -$20.7M | -87.4% |
| FY2021 | -$11.0M | -3.8% |
| FY2020 | -$10.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More HCWB financial trends
HCWB RevenueHCWB Net incomeHCWB Net marginHCWB Gross profitHCWB Gross marginHCWB Operating incomeHCWB Operating marginHCWB Operating cash flowHCWB Capital expendituresHCWB Return on equityHCWB Stock buybacksHCWB Dividends paidHCWB Total assetsHCWB Total liabilitiesHCWB Shareholders’ equityHCWB overview →